
Boston Scientific’s Sean Gayer emphasizes leadership focused on patients
Boston Scientific’s Sean Gayer emphasizes leadership focused on patients
- Sean Gayer, the Vice President for EMEA manufacturing, discusses leadership and the future of healthcare.
- Boston Scientific has invested €75 million in R&D in Galway, reflecting confidence in its Irish operations.
- The podcast emphasizes the importance of leadership that prioritizes patients and employees.
Story
In Ireland, Boston Scientific boasts three manufacturing sites and a workforce of around 8,000 employees, contributing significantly to the medtech sector. Sean Gayer, who took on the role of Vice President for EMEA manufacturing, shared insights during a recent podcast episode, which is part of The Leaders’ Room series created in collaboration with IDA Ireland. His unconventional journey to this position started with a Bachelor of Commerce from University College Cork and continued through various roles in finance and healthcare, where he learned the importance of teamwork and understanding operations at the ground level. In the podcast, Gayer reflects on how critical leadership is in the ever-evolving landscape of healthcare and manufacturing, particularly as society grapples with the implications of an aging population and the demand for innovative medical technologies. He emphasizes the necessity for leaders to adopt a team-player mentality—encouraging engagement with employees directly on the production floor to grasp the core issues that impact operations and the overall success of the company. Gayer’s commitment to leadership principles is informed by the Shingo Prize model, which prioritizes cultural enablers including humility and respect for every individual within the organization. Under his leadership, Boston Scientific Cork successfully achieved a Shingo Prize, which further highlights the effectiveness of these principles in creating a resilient and adaptive manufacturing culture. The company is also focusing on building smarter and more connected factories, aiming to utilize data for improved decision-making processes. As the podcast concluded, it highlighted the strategic investments Boston Scientific is making in Ireland, including a recent €75 million investment in research and development capabilities in Galway. This decision not only reflects the company's confidence in its Irish workforce—amassing over 70,000 years of combined knowledge—but also signals its long-term commitment to innovation and excellence within the medtech field. Gayer’s insights through the podcast serve as a testament to the role effective leadership plays in navigating challenges while keeping patients and employees at the forefront of operational objectives.